respiratori
tract
infect
rti
among
common
diseas
affect
human
typic
symptom
rhiniti
cough
fever
sore
throat
infect
caus
virus
bacteri
rti
less
common
often
develop
viral
infect
children
year
sore
throat
case
caus
virus
adult
group
children
percentag
reduc
virus
associ
rti
picornavirus
human
rhinovirus
hrv
coronavirus
sarscov
merscov
human
coronaviru
hcov
orthoand
paramyxovirus
influenza
viru
parainfluenza
viru
piv
respiratori
syncyti
viru
adenoand
herpesvirus
rti
transmit
person
person
respiratori
droplet
indirectli
via
contamin
surfac
reduct
viral
load
site
infect
reduc
risk
transmiss
via
rout
simultan
reduc
symptom
patient
potenti
spread
infect
lower
respiratori
tract
local
act
lozeng
spray
reach
site
infect
directli
herebi
minim
potenti
side
effect
due
limit
system
uptak
maxim
efficaci
lozeng
contain
antisept
local
anesthet
amylmetacresol
amc
dichlorobenzyl
alcohol
dcba
hexylresorcinol
hr
commonli
use
treat
symptom
sore
throat
oxford
et
al
publish
lozeng
contain
amc
dcba
show
virucid
effect
vitro
three
envelop
virus
rsv
influenza
viru
member
coronaviru
famili
sarscov
howev
activ
nonenvelop
otherwis
specifi
member
adenoviru
group
c
recent
shephard
zybeshari
show
virucid
effect
amcdcba
hr
either
free
substanc
process
lozeng
cytomegaloviru
respect
mechan
virucid
action
clear
howev
author
suggest
denatur
extern
protein
spike
phinduc
rearrang
tertiari
structur
attach
protein
select
effect
viral
lipid
membranesproteinlipid
interact
respons
morpholog
chang
virucid
action
approv
antivir
interact
viral
surfac
iotacarrageenan
high
molecular
weight
sulfat
polym
deriv
red
seawe
antivir
activ
iotacarrageenan
wellestablish
publish
potent
inhibitor
influenza
viru
replic
vitro
vivo
demonstr
antivir
efficaci
common
cold
virus
intranas
administr
sever
random
doubleblind
parallel
group
placebocontrol
clinic
trial
order
treat
viral
throat
infect
develop
lozeng
contain
mg
iotacarrageenanlozeng
activ
ingredi
ten
milligram
chosen
guarante
antivir
activ
throughout
whole
dissolut
process
mouth
lozeng
compon
dilut
due
saliva
product
virus
repres
major
minor
group
hrv
coxsackieviru
one
causal
agent
herpangina
handfootandmouth
diseas
diseas
accompani
pain
lesion
throat
predomin
children
repres
sore
throat
caus
envelop
virus
influenza
viru
hcov
chosen
latter
test
use
hemagglutin
inhibit
hai
assay
next
want
know
whether
carrageenan
liber
lozeng
mouth
suffici
guarante
antivir
activ
throughout
entir
dissolut
process
whether
time
span
suffici
effect
reduc
titer
influenza
viru
hcov
lozeng
weigh
dissolv
ml
water
ph
measur
tabl
medium
assay
vial
place
horizont
shaker
lozeng
dissolv
base
weight
lozeng
volum
solvent
concentr
activ
ingredi
calcul
result
iotacarrageenan
concentr
concentr
dcba
amc
hr
respect
human
rhinoviru
human
cervic
epitheli
carcinoma
cell
line
hela
obtain
american
type
cultur
collect
atcc
manassa
va
usa
cell
cultiv
dulbecco
modifi
eagl
medium
dmem
sigma
aldrich
vienna
austria
supplement
fetal
bovin
serum
sigma
local
anesthet
carrageenan
caus
therapi
sore
throat
aldrich
antibioticantimycot
mix
sigma
aldrich
incub
sanyo
okayama
prefectur
japan
co
rel
humid
experi
medium
contain
fetal
bovin
serum
antibioticantimycot
mix
use
serotyp
obtain
atcc
grown
hela
cell
stock
frozen
viru
titer
determin
tissu
cultur
infect
dose
tcid
assay
human
rhabdomyosarcoma
cell
line
rd
purchas
atcc
cell
cultiv
dmem
sigma
aldrich
supplement
fetal
bovin
serum
sigma
aldrich
antibioticantimycot
mix
sigma
aldrich
incub
sanyo
co
rel
humid
medium
contain
antibioticantimycot
mix
fetal
bovin
serum
use
infect
propag
respect
human
coxsackieviru
obtain
atcc
grown
rd
cell
stock
frozen
viru
titer
determin
tcid
assay
madindarbi
canin
kidney
mdck
cell
obtain
atcc
cultiv
describ
elsewher
influenza
viru
ahansa
kindli
provid
peter
staeh
depart
virolog
univers
freiburg
germani
propag
mdck
cell
describ
elsewher
vero
embryon
african
green
monkey
kidney
cell
purchas
atcc
cell
cultiv
optipro
serum
free
medium
life
technolog
thermo
scientif
waltham
usa
supplement
mm
lglutamin
sigma
aldrich
incub
co
rel
humid
hcov
obtain
atcc
propag
medium
stock
frozen
viru
titer
determin
tcid
assay
lozeng
dissolv
respect
assay
medium
toxic
test
perform
assay
condit
respect
antivir
assay
cell
surviv
assess
resazurin
fluoresc
dye
crystal
violet
hela
rd
cell
crystal
violet
mdck
cell
highest
noncytotox
concentr
use
start
point
subsequ
antivir
activ
assay
cytopath
effect
inhibit
assay
coxsackieviru
cellbas
assay
format
use
test
antivir
effect
differ
lozeng
solut
coxsackieviru
viru
preincub
semilogarithm
dilut
seri
respect
test
sampl
control
minut
room
temperatur
rt
prophylact
treatment
ad
helard
cell
infect
infect
period
minut
rt
cell
wash
medium
cultur
hrv
coxsackieviru
herebi
maintain
concentr
activ
agent
prophylact
treatment
antivir
effect
test
sampl
assess
determin
cell
viabil
use
resazurin
fluoresc
dye
cell
control
infect
absenc
activ
agent
die
incub
cell
dilut
seri
absenc
viral
infect
perform
monitor
potenti
toxic
treatment
enabl
direct
comparison
antivir
effect
lozeng
half
maxim
inhibitori
dilut
id
valu
sampl
calcul
sigmoid
doserespons
model
xlfit
excel
addin
version
valu
correspond
iotacarrageenan
concentr
calcul
lozeng
assay
perform
describ
elsewher
small
adapt
account
high
viscos
lozeng
solut
short
viru
preincub
semilogarithm
dilut
seri
lozeng
control
solut
minut
rt
prophylact
treatment
ad
monolay
mdck
cell
infect
infect
period
minut
rt
inoculum
remov
cell
overlaid
semiliquid
carboxymethylcellulos
medium
cultur
herebi
maintain
concentr
activ
agent
prophylact
treatment
stain
perform
fix
cell
use
antibodi
direct
influenza
viru
nucleoprotein
hors
radish
peroxidas
label
detect
antibodi
tmb
substrat
enabl
direct
comparison
antivir
effect
lozeng
id
valu
sampl
calcul
sigmoid
doserespons
model
xlfit
excel
addin
version
valu
correspond
iotacarrageenan
concentr
calcul
lozeng
highest
nonhemolyt
concentr
test
solut
use
start
point
dilut
seri
viru
work
stock
hcov
influenza
viru
mix
iotacarrageenan
bead
solut
give
final
bead
concentr
vv
ha
titer
correspond
hcov
influenza
viru
particleswel
virusbead
solut
incub
rt
allow
bind
viru
bead
minut
indic
time
point
aliquot
taken
virusbead
complex
remov
centrifug
immedi
supernat
contain
unbound
viru
harvest
kept
rt
refer
maxim
viral
load
absenc
bead
viru
work
stock
adjust
volum
dmem
kept
rt
soon
supernat
harvest
ha
assay
perform
determin
viral
titer
end
serial
dilut
dmem
prepar
duplic
plate
suspens
chicken
rbc
vv
pb
ad
well
allow
hemagglutin
rbc
viru
minut
first
hemolyt
activ
differ
lozeng
solut
determin
case
amcdcbahr
lozeng
applic
dilut
hcov
hai
assay
limit
dilut
lozeng
lozeng
hemolyt
effect
lozeng
solut
chicken
erythrocyt
carrageenan
contain
lozeng
show
hemolyt
effect
data
shown
amcdcbahr
contain
lozeng
test
lozeng
amcdcba
activ
hcov
dilut
contrast
limit
activ
lozeng
carrageenan
reach
assay
condit
indic
least
effect
hcov
activ
amcdcbahr
contain
lozeng
lozeng
effect
test
amcdcbahr
contain
lozeng
mic
carrageenan
figur
effect
lozeng
hr
amcdcba
test
comparison
lozeng
carrageenan
tabl
lozeng
dilut
ml
medium
cytotox
determin
standard
assay
condit
start
minim
toler
dilut
lozeng
lozeng
replic
inhibit
assay
perform
describ
materi
method
section
lozeng
highli
activ
id
valu
correspond
iotacarrageenan
concentr
henc
lozeng
activ
amcdcba
contain
lozeng
time
activ
hr
contain
lozeng
carrageenan
contain
lozeng
also
highli
activ
id
valu
ie
iotacarrageenan
concentr
contrast
none
test
lozeng
show
antivir
effect
test
dilut
indic
least
less
effect
lozeng
effect
lozeng
hr
amcdcba
test
comparison
lozeng
carrageenan
coxsackieviru
lozeng
contain
hr
activ
ingredi
cytotox
dilut
inact
viru
lower
concentr
among
lozeng
contain
amc
dcba
lozeng
show
antivir
effect
coxsackieviru
testabl
concentr
dilut
caus
inhibit
viru
thu
less
activ
lozeng
id
correspond
concentr
carrageenan
tabl
effect
lozeng
hr
amcdcba
test
comparison
lozeng
carrageenan
inhibit
viru
replic
dilut
correspond
iotacarrageenan
concentr
wherea
lozeng
show
effect
dilut
lozeng
show
antivir
activ
test
concentr
tabl
antivir
effect
carrageenan
confer
direct
bind
polym
viral
particl
assay
time
depend
interact
two
repres
respiratori
virus
influenza
viru
hcov
incub
iotacarrageenan
bead
differ
time
point
beadsviru
complex
separ
solut
centrifug
remain
viru
supernat
quantifi
use
classic
ha
assay
within
minut
initi
viral
load
influenza
viru
hcov
particleswel
reduc
within
minut
respect
minut
viral
load
drop
detect
limit
figur
medium
dissolut
time
lozeng
mouth
determin
minut
second
period
viral
titer
reduc
influenza
viru
hcov
respect
oxford
et
al
lozeng
contain
amcdcba
low
ph
current
seri
lozeng
activ
ingredi
differ
flavor
avail
addit
lozeng
market
contain
hr
activ
agent
shephard
zybeshari
test
virucid
effect
amcdcba
hr
either
free
substanc
process
lozeng
experiment
setup
public
lozeng
dilut
ml
artifici
saliva
medium
nine
part
lozeng
solut
directli
mix
one
part
respect
viru
stock
known
titer
differ
contact
time
residu
infect
viru
determin
use
quantit
titrat
oxford
et
al
also
check
morpholog
chang
use
electron
microscopi
found
clump
virus
denatur
spike
protein
within
minut
contact
time
result
conclud
lozeng
contain
either
amcdcba
hr
might
exhibit
local
antivir
effect
patient
sore
throat
due
viral
rti
howev
experiment
setup
allow
extrapol
data
potenti
clinic
effect
dissolut
lozeng
mouth
stimul
saliva
product
result
flow
rate
ml
salivaminut
consequ
ml
saliva
produc
whole
dissolut
process
minut
second
therefor
concentr
matrix
activ
ingredi
effect
amcdcba
hr
contain
lozeng
local
anesthet
carrageenan
caus
therapi
sore
throat
test
time
higher
achiev
concentr
mouth
thu
want
test
set
commerci
avail
amcdcba
hr
contain
lozeng
use
classic
replic
inhibit
assay
varieti
repres
respiratori
virus
chose
member
picornaviru
famili
nonenvelop
coxsackieviru
influenza
viru
repres
orthomyxoviru
famili
envelop
addit
hypothes
denatur
spike
protein
lose
abil
caus
hemagglutin
chicken
erythrocyt
therefor
util
adapt
hai
assay
determin
effect
observ
morpholog
chang
chose
envelop
hcov
repres
coronavirus
respons
rti
amcdcbahr
contain
lozeng
test
head
head
carrageenan
contain
lozeng
allow
differ
lozeng
compar
directli
despit
differ
activ
ingredi
instead
convent
half
maxim
inhibitori
concentr
ic
replic
inhibit
assay
mic
hai
assay
specif
antivir
id
mid
lozeng
solut
calcul
amcdcbahr
contain
lozeng
test
hcov
follow
chosen
evalu
variou
replic
inhibit
assay
due
follow
consider
lozeng
contain
amc
dcba
activ
ingredi
similar
ph
name
nonetheless
lozeng
activ
hcov
wherefor
includ
hrv
coxsackieviru
experi
exclud
possibl
potenti
antivir
activ
rather
result
low
ph
activ
ingredi
lozeng
activ
agent
ph
includ
test
seri
lozeng
ph
test
lozeng
contain
hr
differ
find
oxford
et
al
see
virucid
effect
minor
group
found
amc
dcba
contain
lozeng
slightli
highli
activ
minor
group
respect
lozeng
contain
hr
activ
ingredi
moder
antivir
activ
case
member
major
group
rhinovirus
far
largest
group
rhinovirus
could
confirm
find
oxford
et
al
none
test
amcdcba
hr
contain
lozeng
show
antivir
activ
testabl
concentr
contrast
lozeng
highli
activ
superior
toward
test
test
lozeng
among
lozeng
contain
amcdcba
lozeng
show
antivir
effect
coxsackieviru
testabl
concentr
wherea
lozeng
similar
ph
concentr
activ
ingredi
noneffect
result
indic
neither
low
ph
lozeng
isol
effect
activ
ingredi
rather
one
excipientsaddit
specif
formul
respons
antivir
effect
good
accord
result
shephard
zybeshari
found
pronounc
virucid
effect
placebo
lozeng
could
exclud
potenti
influenc
ph
antivir
activ
reduc
number
amcdcba
hr
contain
lozeng
two
formul
contain
differ
activ
ingredi
lozeng
hr
lozeng
amcdcba
accord
data
publish
oxford
al
found
moder
activ
amcdcba
contain
lozeng
influenza
viru
howev
lozeng
carrageenan
time
effect
inhibit
replic
lozeng
wherea
lozeng
ineffect
testabl
concentr
next
want
know
whether
carrageenan
liber
lozeng
suffici
guarante
antivir
activ
throughout
entir
dissolut
process
whether
time
span
suffici
effect
reduc
titer
influenza
viru
hcov
end
studi
bind
kinet
two
virus
iotacarrageenan
bead
previous
util
bead
studi
mechan
antivir
effect
variou
polym
found
viru
bind
iotacarrageenan
bead
agaros
bead
bind
inhibit
presenc
excess
dissolv
iotacarrageenan
thu
shown
bind
viru
iotacarrageenan
bead
specif
viru
bind
mechan
iotacarrageenan
ident
dissolv
beadcoupl
form
qualifi
iotacarrageenan
bead
use
tool
studi
time
depend
viru
bind
polym
next
determin
averag
lozeng
dissolut
time
real
condit
four
independ
test
subject
dissolv
lozeng
mouth
timespan
need
complet
dissolut
measur
medium
time
calcul
result
minut
data
shown
anoth
experi
found
amount
carrageenan
liber
lozeng
suffici
guarante
antivir
activ
throughout
entir
dissolut
process
carrageenan
begin
dissolut
end
almost
lozeng
left
intern
journal
gener
medicin
intern
peerreview
openaccess
journal
focus
gener
intern
medicin
pathogenesi
epidemiolog
diagnosi
monitor
treatment
protocol
journal
character
rapid
report
review
origin
research
clinic
studi
across
diseas
area
manuscript
manag
system
complet
onlin
includ
quick
fair
peerreview
system
easi
use
visit
http
wwwdovepresscomtestimonialsphp
read
real
quot
publish
author
morokuttikurz
et
al
howev
clear
whether
averag
timespan
observ
dissolut
lozeng
suffici
effect
reduc
titer
repres
respiratori
influenza
viru
hcov
therefor
bind
kinet
repres
influenza
viru
hcov
iotacarrageenan
bead
determin
use
ha
assay
experi
within
first
minut
viral
load
reduc
within
minut
influenza
viru
hcov
respect
minut
viral
load
drop
detect
limit
medium
dissolut
time
lozeng
mouth
determin
minut
second
period
viral
titer
reduc
influenza
hcov
respect
taken
togeth
antivir
effect
amcdcba
hr
contain
lozeng
vari
wide
depend
specif
formul
lozeng
viru
caus
sore
throat
question
suitabl
use
caus
therapi
clinic
set
diseas
caus
viru
mostli
remain
unknown
contrast
carrageenan
contain
lozeng
highli
activ
virus
test
minimum
superior
toward
lozeng
cov
respect
therefor
iotacarrageenan
contain
lozeng
appropri
measur
effect
reduc
number
viral
particl
mouth
use
caus
therapi
viral
infect
throat
